XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

Links shared publicly online about this topic.

704
total visits

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

XenoPort, Inc. announced today that it has been awarded a grant from The Michael J. Fox Foundation for Parkinson's Research to support a preclinical study of the efficacy and safety of a novel, orally administered prodrug of acamprosate in reducing L-Dopa induced dyskinesias (LID) in a pre-clinical model of Parkinson's disease.

View full resource at news-medical.net

Tags: Parkinson's Disease, Stroke, Thrombotic Event, Disease and Condition, News, disease